Stock Price Quote

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE229.402.9 (+1.28 %)
PREV CLOSE ( ) 226.50
OPEN PRICE ( ) 236.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33555
TODAY'S LOW / HIGH ( )226.45 236.25
52 WK LOW / HIGH ( )132.75 307.8
NSE229.333.06 (+1.35 %)
PREV CLOSE( ) 226.27
OPEN PRICE ( ) 230.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 229.33 (1602)
VOLUME 684866
TODAY'S LOW / HIGH( ) 226.50 233.90
52 WK LOW / HIGH ( )133 307.98
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2007
Management Info
Janmejay R Vyas - Chairman Arpit J Vyas - Managing Director
Registered Office

Address Dishman Corporate House,Iscon - Bopal Road,Ambli,
Ahmedabad,
Gujarat-380058

Phone 02717 420102 / 124

Email dishman@dishmangroup.com

Website www.dishmangroup.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

20Mar Dishman Carbogen Amcis’ arm receives C
Dishman Carbogen Amcis’ wholly owned subsidiary -- CARBOGEN AMCIS SAS ha..
20Mar Dishman Carbogen Amcis moves up as its
Dishman Carbogen Amcis is currently trading at Rs. 227.25, up by 0.75 po..
07Mar Allotment of Debentures
Inter alia, to consider and approve the proposal of fund raising by way..
10Jan Dishman Carbogen Amcis’ arm completes
Dishman Carbogen Amcis’ wholly owned subsidiary -- CARBOGEN AMCIS AG has..
14Nov Dishman Carbogen Amcis informs about
Pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and D..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit-132.8-764.1
Gross Profit -193 -1030
Operating Profit 149.5698.5
Net Sales 970.43273.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  8391.50 (6.21%)
M.Cap ( in Cr)20978.75
Neuland Laboratories (BSE)
peergroup  11676.90 (1.44%)
M.Cap ( in Cr)14981.33
Procter&Gamble Healt (BSE)
peergroup  5333.00 (2.08%)
M.Cap ( in Cr)8852.45
Sanofi India (BSE)
peergroup  5702.95 (1.62%)
M.Cap ( in Cr)13134.25
Mankind Pharma (BSE)
peergroup  2246.00 (3.91%)
M.Cap ( in Cr)92665.14

Shareholding Pattern

PROMOTERS 59.32%
NON-INSTITUTION 30.52%
MUTUAL FUNDS/UTI 1.22%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Dishman Carbogen Amcis Ltd.

Dishman Carbogen Amcis Ltd. was incorporated in the year 2007. Its today's share price is 229.4. Its current market capitalisation stands at Rs 3596.6 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3273.5 Cr and Total Income of Rs.3904 Cr. The company's management includes Kulin N Shah, Shrima G Dave, Maitri Mehta, Rajendra S Shah, Arpit J Vyas, Deohooti J Vyas, Janmejay R Vyas.

It is listed on the BSE with a BSE Code of 540701 , NSE with an NSE Symbol of DCAL and ISIN of INE385W01011. It's Registered office is at Dishman Corporate House,Iscon - Bopal Road,AmbliAhmedabad-380058, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Haribhakti & Co LLP, Kunte & Associates., TR Chadha & Co LLP, VD Shukla & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.